BMAA – an unusual cyanobacterial neurotoxin

References

• Arnold A, Edgren DC, Palladino VS. Amyotrophic lateral sclerosis: 50 cases observed on Guam. J Nerv Ment Dis. 1953; 117:135–9.
   PubMed Web of Science ®Google Scholar
• Koerner DR. Amyotrophic lateral sclerosis on Guam. Ann Intern Med. 1952; 37:1204–20.
   PubMed Web of Science ®Google Scholar
• Mulder DW, Kurland LT, Iriarte LL. Neurologic diseases on the island of Guam. U S Armed Forces Med J. 1954; 5:1724–39.
   PubMedGoogle Scholar
• Whiting MG. Toxicity of Cycads. Economic Botany. 1963; 17:271–302.
   Google Scholar
• Kurland LT. Amyotrophic lateral sclerosis and Parkinson's disease complex on Guam linked to an environmental neurotoxin. Trends Neurosci. 1988; 11:51–4.
   PubMed Web of Science ®Google Scholar
• Polsky FI, Nunn PB, Bell EA. Distribution and toxicity of α-amino-ß-methylaminopropionic acid. Fed Proc. 1972; 31:1473–5.
   PubMedGoogle Scholar
• Spencer PS, Nunn PB, Hugon J, Ludolph AC, Ross SM, Roy DN, . Guam amyotrophic lateral sclerosis/Parkinsonism-dementia linked to a plant excitant neurotoxin. Science. 1987; 237:517–22.
   PubMed Web of Science ®Google Scholar
• Duncan MW, Steele JC, Kopin IJ, Markey SP. 2-amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Neurology. 1990; 40:767–72.
   PubMed Web of Science ®Google Scholar
• Ross SM, Seelig M, Spencer PS. Specific antagonism of excitotoxic action of ‘uncommon’ amino acids assayed in organotypic mouse cortical cultures. Brain Res. 1987; 425:120–7.
   PubMed Web of Science ®Google Scholar
• Nunn PB, Seelig M, Zagoren JC, Spencer PS. Stereospecific acute neuronotoxicity of ‘uncommon’ plant amino acids linked to human motor-system diseases. Brain Res. 1987; 410:375–9.
   PubMed Web of Science ®Google Scholar
• Spencer PS, Roy DN, Ludolph A, Hugon J, Dwivedi MP, Schaumburg HH. Lathyrism: evidence for role of the neuroexcitatory amino acid BOAA. Lancet. 1986; 2:1066–7.
   PubMed Web of Science ®Google Scholar
• Teitelbaum JS, Zatorre RJ, Carpenter S, Gendron D, Evans AC, Gjedde A, . Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med. 1990; 322:1781–7.
   PubMed Web of Science ®Google Scholar
• Bridges RJ, Stevens DR, Kahle JS, Nunn PB, Kadri M, Cotman CW. Structure-function studies on N-oxalyl-diamino-dicarboxylic acids and excitatory amino acid receptors: evidence that beta-L-ODAP is a selective non-NMDA agonist. J Neurosci. 1989; 9:2073–9.
   PubMed Web of Science ®Google Scholar
• Debonnel G, Beauchesne L, de Montigny C. Domoic acid, the alleged ‘mussel toxin’, might produce its neurotoxic effect through kainate receptor activation: an electrophysiological study in the dorsal hippocampus. Can J Physiol Pharmacol. 1989; 67:29–33.
   PubMed Web of Science ®Google Scholar
• Weiss JH, Choi DW. ß-N-methylamino-L-alanine neurotoxicity: requirement for bicarbonate as a cofactor. Science. 1988; 241:973–5.
   PubMed Web of Science ®Google Scholar
• Weiss JH, Christine CW, Choi DW. Bicarbonate dependence of glutamate receptor activation by ß-N-methylamino-L-alanine: channel recording and study with related compounds. Neuron. 1989; 3:321–6.
   PubMed Web of Science ®Google Scholar
• Mroz EA. Possible role of carbamates in neurotoxicity and neurotransmitter inactivation. Science. 1989; 243:1615–
   PubMed Web of Science ®Google Scholar
• Myers TG, Nelson SD. Neuroactive carbamate adducts of ß-N-methylamino-L-alanine and ethylenediamine. Detection and quantitation under physiological conditions by 13C NMR. J Biol Chem. 1990; 265:10193–5.
   PubMed Web of Science ®Google Scholar
• Nunn PB, O'Brien P. The interaction of ß-N-methylamino-L-alanine with bicarbonate: an 1H-NMR study. FEBS Lett. 1989; 251:31–5.
   PubMed Web of Science ®Google Scholar
• Weiss JH, Koh JY, Choi DW. Neurotoxicity of ß-N-methylamino-L-alanine (BMAA) and ß-N-oxalylamino-L-alanine (BOAA) on cultured cortical neurons. Brain Res. 1989; 497:64–71.
   PubMed Web of Science ®Google Scholar
• Koh JY, Choi DW. Vulnerability of cultured cortical neurons to damage by excitotoxins: differential susceptibility of neurons containing NADPH-diaphorase. J Neurosci. 1988; 8:2153–63.
   PubMed Web of Science ®Google Scholar
• Weiss JH, Choi DW. Slow non-NMDA receptor mediated neurotoxicity and amyotrophic lateral sclerosis. Adv Neurol. 1991; 56:311–8.
   PubMedGoogle Scholar
• Plaitakis A, Caroscio JT. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1987; 22:575–9.
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Tsai G, Kuncl RW, Clawson L, Cornblath DR, Drachman DB, . Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1990; 28:18–25.
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med. 1992; 326:1464–8.
   PubMed Web of Science ®Google Scholar
• Rothstein JD, van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol. 1995; 38:73–84.
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Forrest V, Ince PG, Richardson JP, Wastell HJ. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration. 1995; 4:209–16.
   PubMedGoogle Scholar
• Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Le Forestier N, . Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci. 2002; 193:73–8.
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci U S A. 1993; 90:6591–5.
   PubMed Web of Science ®Google Scholar
• Carriedo SG, Yin HZ, Weiss JH. Motor neurons are selectively vulnerable to AMPA/kainate receptor- mediated injury in vitro. J Neurosci. 1996; 16:4069–79.
   PubMed Web of Science ®Google Scholar
• Carriedo SG, Yin HZ, Lamberta R, Weiss JH. In vitro kainate injury to large, SMI-32(+) spinal neurons is Ca2+dependent. Neuroreport. 1995; 6:945–8.
   PubMed Web of Science ®Google Scholar
• Hugon J, Vallat JM, Spencer PS, Leboutet MJ, Barthe D. Kainic acid induces early and delayed degenerative neuronal changes in rat spinal cord. Neurosci Lett. 1989; 104:258–62.
   PubMed Web of Science ®Google Scholar
• Ikonomidou C, Qin Qin Y, Labruyere J, Olney JW. Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD1 transgenic mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1996; 55:211–24.
   PubMed Web of Science ®Google Scholar
• Lips MB, Keller BU. Endogenous calcium buffering in motor neurons of the nucleus hypoglossus from mouse. J Physiol. 1998; 511:105–17.
   PubMed Web of Science ®Google Scholar
• Carriedo SG, Sensi SL, Yin HZ, Weiss JH. AMPA exposures induce mitochondrial Ca2+ overload and ROS generation in spinal motor neurons in vitro. J Neurosci. 2000; 20:240–50.
   PubMed Web of Science ®Google Scholar
• van den Bosch L, van den Berghe W, Klaassen H, van Houtte E, Robberecht W. Ca2+ permeable AMPA receptors and selective vulnerability of motor neurons. J Neurol Sci. 2000; 180:29–34.
   PubMed Web of Science ®Google Scholar
• Williams TL, Day NC, Ince PG, Kamboj RK, Shaw PJ. Calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Ann Neurol. 1997; 42:200–7.
   PubMed Web of Science ®Google Scholar
• Kuner R, Groom AJ, Bresink I, Kornau HC, Stefovska V, Muller G, . Late-onset motor neuron disease caused by a functionally modified AMPA receptor subunit. Proc Natl Acad Sci U S A. 2005; 102:5826–31.
   PubMed Web of Science ®Google Scholar
• Tateno M, Sadakata H, Tanaka M, Itohara S, Shin RM, Miura M, . Calcium permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. Hum Mol Genet. 2004; 13:2183–96.
   PubMed Web of Science ®Google Scholar
• van Damme P, Braeken D, Callewaert G, Robberecht W, van den Bosch L. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2005; 64:605–12.
   PubMed Web of Science ®Google Scholar
• Trotti D, Danbolt NC, Volterra A. Glutamate transporters are oxidant vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci. 1998; 19:328–34.
   PubMed Web of Science ®Google Scholar
• Rao SD, Yin HZ, Weiss JH. Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons. J Neurosci. 2003; 23:2627–33.
   PubMed Web of Science ®Google Scholar
• Rao SD, Weiss JH. Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis. Trends Neurosci. 2004; 27:17–23.
   PubMed Web of Science ®Google Scholar
• Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, . Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A. 2002; 99:1604–9.
   PubMed Web of Science ®Google Scholar
• Yin HZ, Tang DT, Weiss JH. Intrathecal infusion of a Ca2+ permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS. Exp Neurol. 2007; 207:177–85.
   PubMed Web of Science ®Google Scholar
• Rao SD, Banack SA, Cox PA, Weiss JH. BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp Neurol. 2006; 201:244–52.
   PubMed Web of Science ®Google Scholar
• Banack SA, Johnson HE, Cheng R, Cox PA. Production of the neurotoxin BMAA by a marine cyanobacterium. Marine Drugs. 2007; 5:180–96.
   PubMed Web of Science ®Google Scholar
• Cox PA, Banack SA, Murch SJ. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Natl Acad Sci U S A. 2003; 100:13380–3.
   PubMed Web of Science ®Google Scholar
• Metcalf JS, Banack SA, Lindsay J, Morrison LF, Cox PA, Codd GA. Co-occurrence of ß-N-methylamino-L-alanine, a neurotoxic amino acid with other cyanobacterial toxins in British waterbodies, 1990–2004. Environ Microbiol. 2008; 10:702–8.
   PubMed Web of Science ®Google Scholar
• Banack SA, Murch SJ, Cox PA. Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. J Ethnopharmacol. 2006; 106:97–104.
   PubMed Web of Science ®Google Scholar
• Banack SA, Cox PA. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS/PDC in Guam. Neurology. 2003; 61:387–9.
   PubMed Web of Science ®Google Scholar
• Murch SJ, Cox PA, Banack SA. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc Natl Acad Sci U S A. 2004; 101:12228–31.
   PubMed Web of Science ®Google Scholar
• Murch SJ, Cox PA, Banack SA, Steele JC, Sacks OW. Occurrence of ß-methylamino-L-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol Scand. 2004; 110:267–9.
   PubMed Web of Science ®Google Scholar
• Pablo J, Banack SA, Cox PA, Johnson TE, Papapetropoulos S, Bradley WG, . Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurol Scand. 2009; 1204:216–25.
   PubMed Web of Science ®Google Scholar
• Smith QR, Nagura H, Takada Y, Duncan MW. Facilitated transport of the neurotoxin, ß-N-methylamino-L-alanine, across the blood-brain barrier. J Neurochem. 1992; 58:1330–7.
   PubMed Web of Science ®Google Scholar
• Lobner D, Piana PM, Salous AK, Peoples RW. ß-N-methylamino-L-alanine enhances neurotoxicity through multiple mechanisms. Neurobiol Dis. 2007; 25:360–6.
   PubMed Web of Science ®Google Scholar
• Nunn PB, Ponnusamy M. ß-N-methylaminoalanine (BMAA). Metabolism and metabolic effects in model systems and in neural and other tissues of the rat in vitro. Toxicon. 2009; 542:85–94.
   PubMed Web of Science ®Google Scholar
• Nunn PB, Davis AJ, O'Brien P. Carbamate formation and the neurotoxicity of L-alpha amino acids. Science. 1991; 251:1619–20.
   PubMed Web of Science ®Google Scholar